|
1.
|
|
13 p, 1.6 MB |
Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis
/
König, Jens Christian (Department of General Pediatrics, University Children's Hospital Münster) ;
Karsay, Rebeka (Department of General Pediatrics, University Children's Hospital Münster) ;
Gerß, Joachim (Institute of Biostatistics and Clinical Research, University of Münster) ;
Schlingmann, Karl-Peter (Department of General Pediatrics, University Children's Hospital Münster) ;
Dahmer-Heath, Mareike (Department of General Pediatrics, University Children's Hospital Münster) ;
Telgmann, Anna-Katharina (Department of General Pediatrics, University Children's Hospital Münster) ;
Kollmann, Sabine (Department of General Pediatrics, University Children's Hospital Münster) ;
Ariceta Iraola, Gema (Hospital Universitari Vall d'Hebron) ;
Gillion, Valentine (Division of Nephrology, Saint-Luc Academic Hospital, Université Catholique Louvain) ;
Bockenhauer, Detlef (Great Ormond Street Hospital for Children (Londres)) ;
Bertholet-Thomas, Aurélia (Centre de Référence des Maladies Rénales Rares-Néphrogones-Hôpital Femme Mère Enfant, Hospices Civils de Lyon-Filière ORKiD) ;
Mastrangelo, Antonio (Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico) ;
Boyer, Olivia (Hôpital Necker-Enfants Malades, Université de Paris) ;
Lilien, Marc (Department of Pediatric Nephrology, University Medical Center Utrecht) ;
Decramer, Stéphane (Université Toulouse III Paul-Sabatier) ;
Schanstra, Joost. P. (Université Toulouse III Paul-Sabatier) ;
Pohl, Martin (Department of Pediatrics, University Hospital Freiburg) ;
Schild, Raphael (University Medical Center Hamburg-Eppendorf) ;
Weber, Stefanie (University Children's Hospital) ;
Hoefele, Julia (Institut für Humangenetik) ;
Drube, Jens (Departement of Pediatric Nephrology, Medical School Hannover) ;
Cetiner, Metin (Department of Pediatric Nephrology, University of Duisburg-Essen) ;
Hansen, Matthias (Clementine Kinderhospital) ;
Thumfart, Julia (Charité - Universitätsmedizin Berlin) ;
Tönshoff, Burkhard (Department of Pediatrics I, University Children's Hospital Heidelberg) ;
Habbig, Sandra (Department of Pediatric, University of Cologne) ;
Liebau, Max Christoph (University Hospital Cologne and Medical) ;
Bald, Martin (Children's Hospital (Alemanya)) ;
Bergmann, Carsten (Medizinische Genetik Mainz (Alemanya)) ;
Pennekamp, Petra (Department of General Pediatrics, University Children's Hospital Münster) ;
Konrad, Martin (Department of General Pediatrics, University Children's Hospital Münster) ;
Universitat Autònoma de Barcelona
Nephronophthisis (NPH) comprises a group of rare disorders accounting for up to 10% of end-stage kidney disease (ESKD) in children. Prediction of kidney prognosis poses a major challenge. We assessed differences in kidney survival, impact of variant type, and the association of clinical characteristics with declining kidney function. [...]
2022 -  10.1016/j.ekir.2022.05.035
Kidney International Reports, Vol. 7 (june 2022) , p. 2016-2028
|
|
|
2.
|
|
11 p, 703.6 KB |
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
/
Buxeda, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Arias Cabrales, Carlos E (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Pérez-Sáez, María josé (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Cacho, Judit (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cabello Pelegrin, Sheila (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Melilli, Edoardo (Hospital Universitari de Bellvitge) ;
Aladrén, María José (Hospital Universitario Miguel Servet (Saragossa)) ;
Galeano Alvarez, Cristina (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ;
Lorenzo, Iinmaculada (Complejo Hospitalario Universitario de Albacete) ;
Mazuecos, Auxiliadora (Hospital Universitario Puerta del Mar (Cadis, Andalusia)) ;
Saura, Isabel María (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Franco, Antonio (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Ruiz-Fuentes, María del Carmen. (Hospital Universitario Virgen de las Nieves (Granada)) ;
Sánchez-Cámara, Luis Alberto (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Siverio, Orlando (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ;
Martin, María Luisa (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
González-García, Elena (Hospital Universitario La Paz (Madrid)) ;
López, Verónica (Instituto de Investigación Biomédica de Málaga) ;
Martin-Moreno, Paloma Leticia (Instituto de Investigación Sanitaria de Navarra) ;
Moina, Iñigo (Hospital de Basurto (Bilbao, Biscaia)) ;
Moral Berrio, Esperanza (Hospital General Universitario de Ciudad Real) ;
Moreso, Francesc (Hospital Universitari Vall d'Hebron) ;
Portolés, José María (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Santana-Estupiñán, Raquel (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Zárraga, Sofía (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Canal Girol, Cristina (Institut d'Investigació Biomèdica Sant Pau) ;
Sánchez-Álvarez, Emilio (Hospital Universitario de Cabueñes (Gijón)) ;
Pascual, Julio (Pascual Santos) (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Crespo, Marta (Institut Hospital del Mar d'Investigacions Mèdiques)
Introduction: Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury have been reported. [...]
2021 - 10.1016/j.ekir.2021.06.023
Kidney International Reports, Vol. 6 Núm. 9 (september 2021) , p. 2305-2315
|
|
|
3.
|
|
|
4.
|
|
11 p, 1.4 MB |
Hepatic Lactate Dehydrogenase A : An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
/
Ariceta Iraola, Gema (Hospital Universitari Vall d'Hebron) ;
Barrios, Kelly (Dicerna Pharmaceuticals, Inc., Lexington) ;
Brown, Bob D. (Dicerna Pharmaceuticals, Inc., Lexington) ;
Hoppe, Bernd (German Hyperoxaluria Center Cologne/Bonn) ;
Rosskamp, Ralf (Dicerna Pharmaceuticals, Inc., Lexington) ;
Langman, Craig B. (Ann and Robert H. Lurie Children's Hospital of Chicago) ;
Universitat Autònoma de Barcelona
Primary hyperoxaluria (PH) is a family of 3 rare genetic disorders of hepatic glyoxylate metabolism that lead to overproduction and increased renal excretion of oxalate resulting in progressive renal damage. [...]
2021 - 10.1016/j.ekir.2021.01.029
Kidney International Reports, Vol. 6 (february 2021) , p. 1088-1098
|
|
|
5.
|
|
5 p, 1.6 MB |
Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial
/
Raggi, Paolo (Division of Cardiology and Department of Medicine, University of Alberta, Edmonton, Alberta, Canada) ;
Bellasi, Antonio (Research, Innovation and Brand Reputation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy) ;
Sinha, Smeeta (Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, United Kingdom) ;
Bover, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Rodriguez, Mariano (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Ketteler, Markus (Department of General Internal Medicine and Nephrology, Robert-Bosch-Krankenhaus, Stuttgart, Germany) ;
Bushinsky, David A. (Department of Medicine, University of Rochester School of Medicine, Rochester, New York, USA) ;
Garg, Rekha (PharmaDRS, LLC, San Diego, California, USA) ;
Perelló, Joan (University of the Balearic Islands, Palma, Spain) ;
Gold, Alex (Department of Medicine, Stanford University, Palo Alto, California, USA) ;
Chertow, Glenn M. (Department of Medicine, Stanford University, Palo Alto, California, USA) ;
Universitat Autònoma de Barcelona
Coronary artery calcium (CAC) is highly prevalent and linked with poor outcomes in patients receiving maintenance hemodialysis, and its reduction may improve patient prognosis. SNF472, a selective inhibitor of hydroxyapatite crystallization, slows CAC progression in patients receiving maintenance hemodialysis. [...]
2020 - 10.1016/j.ekir.2020.09.032
Kidney International Reports, Vol. 5 (november 2020) , p. 2178-2182
|
|
|
6.
|
|
3 p, 133.9 KB |
Feasible Low-Phosphorus Dietary Patterns in Maintenance Hemodialysis Patients : Need for Original Research
/
Bover, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Molina, Pablo (Hospital Universitari Doctor Peset (València)) ;
Ureña-Torres, Pablo (Department of Renal Physiology, Necker Hospital, University of Paris Descartes, Paris, France) ;
Arenas Jimenez, Maria Dolores (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Universitat Autònoma de Barcelona
2020 - 10.1016/j.ekir.2020.09.008
Kidney International Reports, Vol. 5 (september 2020) , p. 1845-1847
|
|
|
7.
|
|
12 p, 571.6 KB |
Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus
/
Torres, Armando (Hospital Universitario de Canarias (La Laguna)) ;
Hernández, Domingo (Instituto de Investigación Biomédica de Málaga) ;
Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Seron, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Burgos, María Dolores (Instituto de Investigación Biomédica de Málaga) ;
Pallardó, Luis M. (Hospital Universitari Doctor Peset (València)) ;
Kanter, Julia (Hospital Universitari Doctor Peset (València)) ;
Díaz Corte, Carmen (Hospital Universitario Central de Asturias) ;
Rodríguez, Minerva (Hospital Universitario Central de Asturias) ;
Díaz Gómez, Juan Manuel (Institut d'Investigació Biomèdica Sant Pau) ;
Silva, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Valdes, Francisco (Complejo Hospitalario Universitario de A Coruña) ;
Fernández-Rivera, Constantino (Complejo Hospitalario Universitario de A Coruña) ;
Osuna, Antonio (Hospital Universitario Virgen de las Nieves (Granada)) ;
Gracia Guindo, María C. (Hospital Universitario Virgen de las Nieves (Granada)) ;
Gómez Alamillo, Carlos (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Ruiz, Juan C. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Marrero Miranda, Domingo (Hospital Universitario de Canarias (La Laguna)) ;
Pérez-Tamajón, Lourdes (Hospital Universitario de Canarias (La Laguna)) ;
Rodríguez, Aurelio (Hospital Universitario de Canarias (La Laguna)) ;
González-Rinne, Ana (Hospital Universitario de Canarias (La Laguna)) ;
Alvarez, Alejandra (Hospital Universitario de Canarias (La Laguna)) ;
Perez-Carreño, Estefanía (Hospital Universitario de Canarias (La Laguna)) ;
de la Vega Prieto, María José (Hospital Universitario de Canarias (La Laguna)) ;
Henriquez, Fernando (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Gallego Samper, Roberto (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Salido, Eduardo (Hospital Universitario de Canarias (La Laguna)) ;
Porrini, Esteban (Hospital Universitario de Canarias (La Laguna)) ;
Universitat Autònoma de Barcelona
Despite the high incidence of posttransplant diabetes mellitus (PTDM) among high-risk recipients, no studies have investigated its prevention by immunosuppression optimization. We conducted an open-label, multicenter, randomized trial testing whether a tacrolimus-based immunosuppression and rapid steroid withdrawal (SW) within 1 week (Tac-SW) or cyclosporine A (CsA) with steroid minimization (SM) (CsA-SM), decreased the incidence of PTDM compared with tacrolimus with SM (Tac-SM). [...]
2018 - 10.1016/j.ekir.2018.07.009
Kidney International Reports, Vol. 3 (july 2018) , p. 1304-1315
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
